Industry Symposia 2026 - 4th of September
British Summer Time (BST) No CPD credits
IUCS is a sponsored event. All companies sponsoring the event are named and have no input into the content of the programme, arrangement of the event, or the selection of speakers, except in the case of dedicated sponsored symposium sessions, which are clearly identified in the conference programme. IUCS receives exhibition sponsorship from pharmaceutical companies and other trade partners.
IUCS recognise the ABPI Code of Practice and the implications for pharmaceutical companies that support the Annual meeting by way of sponsoring. Industry partners have no input into the educational content of the programme outside of sponsored industry symposium and stands.
10:25- 10:45
Evidence & experience, shaping decisions in advanced urothelial carcinoma
Professor Syed Hussain, Professor and Honorary Consultant in Medical Oncology, University of Sheffield Teaching Hospitals NHS Trust, UK
Merck organised and funded promotional symposium
12:20- 12:50
IN PRESENCE ONLY
Redefining MIBC care together an AstraZeneca promotional symposia
Dr Christos Mikropoulos – Consultant Oncologist Royal Surrey NHS trust, UK
14:50- 15:10
Is single agent TKI still an option in selected mRCC patients?
Dr Pasquale Rescigno, Consultant Medical Oncologist, Northern Centre for Cancer Care, Newcastle, UK.
This promotional symposium is sponsored by Recordati UK Ltd and is intended for healthcare professionals only. IE-FOT-0070 / August 2026
15:10- 15:30
Cancer and Cardiovascular disease - what every oncologist needs to know
Dr. Siva Tharshini Ramalingam, GP Partner at Oxted Health Centre in Surrey and an ICOS board-certified cardio-oncologist at The Royal Brompton Hospital, London, UK